(ELIS) Elis - Ratings and Ratios
Linen, Workwear, Hygiene Services
Description: ELIS Elis
Elis SA is a global provider of linen rental, workwear, and hygiene services, operating across multiple regions including Europe, Latin America, and internationally. The company offers a comprehensive range of services and products, including linen rental, workwear and personal protective equipment, hygiene solutions, and waste management services, catering to various industries such as catering, healthcare, and industries.
Key Performance Indicators (KPIs) that can be used to evaluate Elis SAs performance include revenue growth, EBITDA margin, and return on equity (RoE). With a RoE of 17.39%, the company demonstrates a strong ability to generate profits from shareholder equity. Additionally, the companys diversified service offerings and global presence provide a stable foundation for long-term growth.
Elis SAs business model is characterized by a strong focus on recurring revenue streams, driven by its linen rental and hygiene services. The companys ability to maintain a high level of customer retention and attract new clients is crucial to its success. Key metrics to monitor include customer acquisition costs, customer retention rates, and average revenue per user (ARPU).
The companys financial health can be assessed by examining its debt-to-equity ratio, interest coverage ratio, and cash flow generation. A strong financial position enables Elis SA to invest in growth initiatives, such as expanding its service offerings and entering new markets, while also returning value to shareholders through dividends or share buybacks.
ELIS Stock Overview
| Market Cap in USD | 6,728m |
| Sub-Industry | Diversified Support Services |
| IPO / Inception |
ELIS Stock Ratings
| Growth Rating | 88.8% |
| Fundamental | 74.2% |
| Dividend Rating | 54.0% |
| Return 12m vs S&P 500 | 3.10% |
| Analyst Rating | - |
ELIS Dividends
| Dividend Yield 12m | 1.81% |
| Yield on Cost 5y | 4.56% |
| Annual Growth 5y | 7.80% |
| Payout Consistency | 72.3% |
| Payout Ratio | 30.4% |
ELIS Growth Ratios
| Growth Correlation 3m | -33.4% |
| Growth Correlation 12m | 84% |
| Growth Correlation 5y | 86.5% |
| CAGR 5y | 28.77% |
| CAGR/Max DD 3y (Calmar Ratio) | 1.31 |
| CAGR/Mean DD 3y (Pain Ratio) | 4.41 |
| Sharpe Ratio 12m | 0.64 |
| Alpha | -1.27 |
| Beta | 1.574 |
| Volatility | 22.67% |
| Current Volume | 231.9k |
| Average Volume 20d | 223.7k |
| Stop Loss | 24 (-3.4%) |
| Signal | 0.52 |
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (614.0m TTM) > 0 and > 6% of Revenue (6% = 547.5m TTM) |
| FCFTA 0.12 (>2.0%) and ΔFCFTA 7.48pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -8.24% (prev -9.67%; Δ 1.43pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.30 (>3.0%) and CFO 2.75b > Net Income 614.0m (YES >=105%, WARN >=100%) |
| Net Debt (3.83b) to EBITDA (3.10b) ratio: 1.24 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.66 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (258.9m) change vs 12m ago -1.70% (target <= -2.0% for YES) |
| Gross Margin 42.57% (prev 42.30%; Δ 0.27pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 100.6% (prev 76.65%; Δ 23.91pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.08 (EBITDA TTM 3.10b / Interest Expense TTM 291.6m) >= 6 (WARN >= 3) |
Altman Z'' 1.03
| (A) -0.08 = (Total Current Assets 1.49b - Total Current Liabilities 2.24b) / Total Assets 9.17b |
| (B) 0.15 = Retained Earnings (Balance) 1.33b / Total Assets 9.17b |
| (C) 0.13 = EBIT TTM 1.19b / Avg Total Assets 9.07b |
| (D) 0.20 = Book Value of Equity 1.14b / Total Liabilities 5.60b |
| Total Rating: 1.03 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 74.18
| 1. Piotroski 6.50pt = 1.50 |
| 2. FCF Yield 10.78% = 5.0 |
| 3. FCF Margin 11.57% = 2.89 |
| 4. Debt/Equity 1.14 = 1.89 |
| 5. Debt/Ebitda 1.24 = 1.41 |
| 6. ROIC - WACC (= 4.32)% = 5.40 |
| 7. RoE 17.45% = 1.45 |
| 8. Rev. Trend 68.35% = 5.13 |
| 9. EPS Trend -9.94% = -0.50 |
What is the price of ELIS shares?
Over the past week, the price has changed by +3.33%, over one month by +4.55%, over three months by +0.49% and over the past year by +20.03%.
Is Elis a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ELIS is around 28.23 EUR . This means that ELIS is currently undervalued and has a potential upside of +13.65% (Margin of Safety).
Is ELIS a buy, sell or hold?
What are the forecasts/targets for the ELIS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 27.7 | 11.4% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 31.2 | 25.6% |
ELIS Fundamental Data Overview
Market Cap EUR = 5.77b (5.77b EUR * 1.0 EUR.EUR)
P/E Trailing = 16.7703
P/E Forward = 11.7786
P/S = 1.2357
P/B = 1.6172
Beta = 1.574
Revenue TTM = 9.12b EUR
EBIT TTM = 1.19b EUR
EBITDA TTM = 3.10b EUR
Long Term Debt = 2.34b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.23b EUR (from shortTermDebt, last quarter)
Debt = 4.06b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.83b EUR (from netDebt column, last quarter)
Enterprise Value = 9.79b EUR (5.77b + Debt 4.06b - CCE 39.3m)
Interest Coverage Ratio = 4.08 (Ebit TTM 1.19b / Interest Expense TTM 291.6m)
FCF Yield = 10.78% (FCF TTM 1.06b / Enterprise Value 9.79b)
FCF Margin = 11.57% (FCF TTM 1.06b / Revenue TTM 9.12b)
Net Margin = 6.73% (Net Income TTM 614.0m / Revenue TTM 9.12b)
Gross Margin = 42.57% ((Revenue TTM 9.12b - Cost of Revenue TTM 5.24b) / Revenue TTM)
Gross Margin QoQ = 45.74% (prev 46.24%)
Tobins Q-Ratio = 1.07 (Enterprise Value 9.79b / Total Assets 9.17b)
Interest Expense / Debt = 1.82% (Interest Expense 74.0m / Debt 4.06b)
Taxrate = 29.27% (63.1m / 215.6m)
NOPAT = 840.7m (EBIT 1.19b * (1 - 29.27%))
Current Ratio = 0.66 (Total Current Assets 1.49b / Total Current Liabilities 2.24b)
Debt / Equity = 1.14 (Debt 4.06b / totalStockholderEquity, last quarter 3.58b)
Debt / EBITDA = 1.24 (Net Debt 3.83b / EBITDA 3.10b)
Debt / FCF = 3.62 (Net Debt 3.83b / FCF TTM 1.06b)
Total Stockholder Equity = 3.52b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.69% (Net Income 614.0m / Total Assets 9.17b)
RoE = 17.45% (Net Income TTM 614.0m / Total Stockholder Equity 3.52b)
RoCE = 20.28% (EBIT 1.19b / Capital Employed (Equity 3.52b + L.T.Debt 2.34b))
RoIC = 11.79% (NOPAT 840.7m / Invested Capital 7.13b)
WACC = 7.47% (E(5.77b)/V(9.83b) * Re(11.82%) + D(4.06b)/V(9.83b) * Rd(1.82%) * (1-Tc(0.29)))
Discount Rate = 11.82% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.47%
[DCF Debug] Terminal Value 70.15% ; FCFE base≈777.9m ; Y1≈959.7m ; Y5≈1.64b
Fair Price DCF = 67.06 (DCF Value 15.59b / Shares Outstanding 232.5m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: -9.94 | EPS CAGR: -53.00% | SUE: 0.0 | # QB: 0
Revenue Correlation: 68.35 | Revenue CAGR: 23.75% | SUE: N/A | # QB: 0